블로그
-
TCI(국소 칼시뉴린 억제제)-사용시 알아야할 내용/무엇이 나의 아이를 아토피 피부염 환자로 만드는가
For patients with AD
blog.naver.com · 2021.08.18
-
TCI(국소 칼시뉴린 억제제)-사용시 알아야할 내용/무엇이 나의 아이를 아토피 피부염 환자로 만드는가
For patients with AD
blog.naver.com · 2021.08.18
-
[공유] 로슈 관절염 치료제, 코로나19 사망률 낮춘다
Treatment with tocilizumab significantly reduced deaths: 596 (29%) of the patients in the tocilizumab group died within 28 days compared with 694 (33%) patients in the usual care group (rate ratio 0·86;
blog.naver.com · 2021.02.15
-
논문게재 - 세계적인 국제 학술지인 ‘알츠하이머 연구 및 치료' (Alzheimer's Research & Therapy I.F 6.116)에 게재
Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer’s disease already receiving
blog.naver.com · 2021.03.27
-
[FDA, 200616] 마일로타그, CD33+ 급성 골수성 백혈병 허가
Pharmaceuticals LLC) for newly-diagnosed CD33-positive acute myeloid leukemia (AML) to include pediatric patients with newly-diagnosed AML ages 0 to.......
blog.naver.com · 2020.06.30
-
[FDA, 200610] 옵디보, 식도편평세포암종 허가
2020, the Food and Drug Administration approved nivolumab (OPDIVO, Bristol-Myers Squibb Co.) for patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC) after
blog.naver.com · 2020.06.14
-
[FDA, 200615] 제프젤카, 소세포암 허가
Administration granted accelerated approval to lurbinectedin(ZEPZELCA, Pharma Mar S.A.) for adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy
blog.naver.com · 2020.06.30
-
[FDA, 200616] 키트루다, 고형암 환자 대상 허가
approval to pembrolizumab (KEYTRUDA, Merck & Co., Inc.) for the treatment of adult and pediatric patients with unresectable or metastatic tumor mutational burden-high (TMB-H) [≥10 mutations/megabase (mut/Mb
blog.naver.com · 2020.06.30
-
Rosenhan (1973)
Sane in insane places; Field study with elements of participants observation Aims: to investigate whether - 8 mentally healthy subjects tried to gain admission to psychiatric hospitals - In the interview with
blog.naver.com · 2020.04.28
-
2019년 추나요법 급여 1차 사전교육
With Chuna Manipulative Therapy conducted by KMD, I hope many patients co.......
blog.naver.com · 2020.05.18
